A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results
- PMID: 3896555
A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results
Abstract
Cyclosporine has gained acceptance as the immunosuppressive agent of choice in cardiac transplantation, but the validity of this assumption has yet to be established. Since January 1983, 25 patients have been randomly assigned to receive either conventional immunosuppression (azathioprine/antithymocyte globulin/prednisone) and pretransplant transfusion (PAAP, n = 11) or cyclosporine immunosuppression (cyclosporine and prednisone [CyA], n = 14). There was no difference in the age distribution (41 +/- 9 vs 38 +/- 11 years), indications for transplantation, preoperative serum creatinine level (1.2 +/- 0.2 vs 1.4 +/- 0.3 mg/dl), or postoperative follow-up time (13.5 +/- 5.4 vs 13.5 +/- 5.2 months). Mortality was not different (PAAP = 2, CyA = 3) and there was no difference in rejection episodes per patient (PAAP = 1.8, CyA = 1.9). Patients in the PAAP group had more serious infections (PAAP = 8, CyA = 3; P less than .02), but those in the CyA group developed a greater incidence of systemic hypertension (PAAP = 1, CyA = 10; p less than .02), pericardial effusion (PAAP = 0, CyA = 6; p = .05), and impaired renal function (creatinine 1.5 mg/dl, PAAP = 2, CyA = 11; p less than .02). Thus it appears that in this small series, cyclosporine is not associated with a significant increase in early survival. It does appear that patients on PAAP immunosuppression develop a greater number of serious infections, but the incidence of rejection episodes appears to be the same. Renal dysfunction and hypertension in patients receiving cyclosporine continue to be long-term concerns and may add to the morbidity and mortality of patients treated with this immunosuppressive regimen.
Similar articles
-
Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.J Heart Transplant. 1985 Jul-Aug;4(4):381-4. J Heart Transplant. 1985. PMID: 3916511 Clinical Trial.
-
Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.J Thorac Cardiovasc Surg. 1989 Nov;98(5 Pt 2):951-5. J Thorac Cardiovasc Surg. 1989. PMID: 2811426
-
Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.N Engl J Med. 1988 Jun 9;318(23):1499-507. doi: 10.1056/NEJM198806093182304. N Engl J Med. 1988. PMID: 3285215 Clinical Trial.
-
[Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].Gastroenterol Clin Biol. 1994;18(2):115-22. Gastroenterol Clin Biol. 1994. PMID: 8013792 Review. French.
-
Immunosuppression following cardiac transplantation.Cardiol Clin. 1990 Feb;8(1):83-96. Cardiol Clin. 1990. PMID: 2407363 Review.
Cited by
-
Progress Toward Cardiac Xenotransplantation.Circulation. 2020 Oct 6;142(14):1389-1398. doi: 10.1161/CIRCULATIONAHA.120.048186. Epub 2020 Oct 5. Circulation. 2020. PMID: 33017208 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical